adenosine has been researched along with Cerebrovascular Disorders in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, T; Freeman, WD; Hanel, RA; Johns, G; Miller, DA; Navarro, R; Nordeen, JD; Sapin, M; Taussky, P; Tawk, RG | 1 |
| Arrich, J; Gouya, G; Gurbel, PA; Huber, K; Pirker-Kees, A; Siller-Matula, JM; Verheugt, FW; Wolzt, M | 1 |
| Amsallem, M; Bal dit Sollier, C; Dillinger, JG; Drouet, L; Henry, P; Manzo-Silberman, S; Sideris, G; Voicu, S | 1 |
| Liu, H; Xia, Y | 1 |
| DiNicolantonio, JJ; Serebruany, VL | 1 |
| Selley, ML | 1 |
| Foster, AC; Miller, LP; Wiesner, JB | 1 |
| Araki, T; Kogure, K; Nagasawa, H | 1 |
| Hara, S; Matsumura, M; Ueda, M | 1 |
| Jacobson, KA; Lin, RC; Von Lubitz, DK | 1 |
| Abbracchio, MP; Picano, E | 1 |
| Lavados, PM; Oppenheimer, SM; Razumovsky, AY; Sen, S; Zanferrari, C | 1 |
| Heikkinen, ER | 1 |
| Marangos, PJ | 1 |
| Anwar, M; Weiss, HR | 1 |
| Palmer, GC | 1 |
| Hashimoto, T; Hayakawa, T; Ikeda, T; Jamshidi, J; Masana, Y; Mogami, H; Morimoto, K | 1 |
| Hankiewicz, J; Lesniak, M | 1 |
| Cavalieri, U; Leonelli, G | 1 |
4 review(s) available for adenosine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Topics: Adenosine; Aged; Aspirin; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel; Cohort Studies; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Population; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Secondary Prevention; Stroke; Thiophenes; Ticagrelor; Ticlopidine; Vascular Diseases | 2014 |
Beneficial and detrimental role of adenosine signaling in diseases and therapy.
Topics: Adenosine; Animals; Cerebrovascular Disorders; Chronic Disease; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, G-Protein-Coupled; Receptors, Purinergic P1; Respiration Disorders; Signal Transduction | 2015 |
Regulation of endogenous adenosine levels in the CNS: potential for therapy in stroke, epilepsy and pain.
Topics: Adenosine; Animals; Central Nervous System; Central Nervous System Diseases; Cerebrovascular Disorders; Epilepsy; Homeostasis; Humans; Pain; Receptors, Purinergic P1 | 1994 |
Cyclic nucleotides in stroke and related cerebrovascular disorders.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine; Adenylyl Cyclases; Animals; Brain; Brain Ischemia; Brain Neoplasms; Capillaries; Cerebrovascular Disorders; Cyclic AMP; Cyclic GMP; gamma-Aminobutyric Acid; Guanylate Cyclase; Humans; Hypoxia, Brain; In Vitro Techniques; Lactates; Lactic Acid; Norepinephrine; Phospholipids; Protein Kinases; Synaptic Membranes; Tissue Distribution | 1985 |
2 trial(s) available for adenosine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Comparing ticagrelor versus clopidogrel in patients with a history of cerebrovascular disease: a net clinical harm?
Topics: Adenosine; Cerebrovascular Disorders; Clopidogrel; Humans; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor; Ticlopidine; United States; United States Food and Drug Administration | 2012 |
European Stroke Prevention Study-2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation?
Topics: Adenosine; Aspirin; Blood-Brain Barrier; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Neuroprotective Agents; Placebos; Platelet Aggregation Inhibitors | 1998 |
13 other study(ies) available for adenosine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Safety and efficacy of ticagrelor for neuroendovascular procedures. A single center initial experience.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cerebrovascular Disorders; Clopidogrel; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Retrospective Studies; Stents; Ticagrelor; Ticlopidine; Treatment Outcome | 2014 |
Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy.
Topics: Adenosine; Aged; Aspirin; Cerebrovascular Disorders; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Secondary Prevention; Thiophenes; Ticagrelor; Ticlopidine | 2015 |
Increased homocysteine and decreased adenosine formation in Alzheimer's disease.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cerebrovascular Disorders; Down-Regulation; Female; Homocysteine; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Neuroprotective Agents; Predictive Value of Tests; S-Adenosylhomocysteine; Up-Regulation | 2004 |
Alteration of adenosine A1 receptor binding in the post-ischaemic rat brain.
Topics: Adenosine; Animals; Autoradiography; Brain; Cerebrovascular Disorders; Humans; Ischemic Attack, Transient; Male; Organ Specificity; Rats; Rats, Wistar; Receptors, Purinergic P1; Reference Values; Substantia Nigra; Thalamus; Time Factors; Tritium | 1994 |
Studies of cardiovascular responses to some endogenous pressor and hypotensive agents in conscious stroke-prone spontaneously hypertensive rats of different ages.
Topics: Acetylcholine; Adenosine; Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiovascular Agents; Cerebrovascular Disorders; Heart Rate; Hemodynamics; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1993 |
Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
Topics: Adenosine; Animals; Brain Ischemia; Caffeine; Cell Survival; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Female; Gerbillinae; Hippocampus; Laser-Doppler Flowmetry; Neurons; Phenethylamines; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Treatment Outcome | 1995 |
Effect of adenosine on cerebral blood flow velocity.
Topics: Adenosine; Adult; Aged; Analysis of Variance; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Middle Cerebral Artery; Prospective Studies; Pulsatile Flow; Ultrasonography, Doppler, Transcranial; Vasodilator Agents | 2001 |
Experimental cerebrovascular disorders: effects of papaverine and theophylline.
Topics: Adenosine; Animals; Cerebrospinal Fluid Proteins; Cerebrovascular Disorders; Cyclic AMP; Drug Evaluation, Preclinical; Female; Male; Papaverine; Rabbits; Theophylline | 1977 |
Adenosinergic approaches to stroke therapeutics.
Topics: Adenosine; Aspartic Acid; Cerebrovascular Disorders; Glutamates; Glutamic Acid; Humans; Receptors, Purinergic | 1990 |
Adenosine and cerebral capillary perfusion and blood flow during middle cerebral artery occlusion.
Topics: Adenosine; Animals; Arterial Occlusive Diseases; Arterioles; Blood Volume; Capillaries; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Ligation; Male; Rats; Time Factors | 1989 |
[Cerebrospinal fluid concentrations of creatinine and purine metabolites determined by high performance liquid chromatography: preliminary report on head injury and stroke patients].
Topics: Adenosine; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Craniocerebral Trauma; Creatinine; Humans; Hypoxanthine; Hypoxanthines; Inosine; Uric Acid | 1987 |
Adenosine deaminase in cerebrospinal fluid.
Topics: Adenosine; Adolescent; Adult; Aged; Aminohydrolases; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebellum; Cerebrospinal Fluid Proteins; Cerebrovascular Disorders; Child; Chlorides; Epilepsy; Female; Glioma; Glucose; Humans; Male; Meningioma; Meningitis; Middle Aged | 1972 |
[Preliminary clinico-geriatric trials of S-adenosylmethionine (coenzyme of biologic transmethylation)].
Topics: Adenosine; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Humans; Injections, Intramuscular; Liver Diseases; Male; Mental Disorders; Methionine; S-Adenosylmethionine | 1972 |